4/19/2024:
https://investorshangout.com/post/view?id=6686199

03/25/2025:
https://investorshangout.com/post/view?id=6751885

4/16/2025:
https://investorshangout.com/post/view?id=6755522

09/12/2025
My69z

Google says:
Diagnostic and Laboratory Disposables:
This is the most lucrative segment within the medical disposables market, showing the fastest growth.

Cytodyn, find a way to secure a % of Assay test fees, from Creativ-bio -- with a 1st Right Refusal
___

08/27/2025
My69z

Screening & Early Detection: LifeTracDx® may detect cancer in patients with no prior history, across all stages and in multiple organs.

( LL+Creativ+ICI combo could be prophylactic )

Real-time insights into cancer aggressiveness: LifeTracDx® may determine the aggressiveness of the patient’s cancer at any time.

(There's our CRC real-time viewing)
___
9/25/2025
My69z

Creatv Bio has analyzed patient samples from over 30 types of cancer, including both solid tumors and blood cancers.

( as of Aug. video we're testing PD-L1 of 9 cancers )

* The team also aims to secure insurance and Medicare reimbursement,

* Our ultimate goal is to get the LifeTracDx® information out to oncologists so they can provide better treatment of their patients,”

( I've wondered if Creativ seeking FDA approval was an aspect of seemingly our trials being delayed. The Aug video was a floodgate of PD-L1 observing )

Never really looked @ Creativ until now. Unmatched betterment for humanity collaboration:

LL+Creativ+ICI

https://theceoviews.com/creatvbio-revolutioni...agnostics/
_____

Nov. 24th, 2025.
Add to the Creativ Micro now discussions across boards. It's exactly what Dr. Adam's addressed in October:

Immunogenicity Prediction & Control

https://stocktwits.com/my69z/message/637334800
___

Saying it again today, Cytodyn should score a % equity of Creativ assay sales.

Especially if the FDA ok's Cytodyn trials as route for Creativ's LifeTracDx & Sieve moving beyond current lab/testing, to FDA approved tests, for trial Approvals